Form 8-K - Current report:
SEC Accession No. 0001213900-26-039986
Filing Date
2026-04-03
Accepted
2026-04-03 16:33:53
Documents
14
Period of Report
2026-03-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0285112-8k_drugs2.htm   iXBRL 8-K 35545
2 DEFINITIVE INVESTMENT AND SPONSOR TRANSITION AGREEMENT ea028511201ex10-1.htm EX-10.1 36711
3 GRAPHIC ea028511201_ex10-1img1.jpg GRAPHIC 2446
  Complete submission text file 0001213900-26-039986.txt   300895

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE dmiiu-20260324.xsd EX-101.SCH 4163
5 XBRL DEFINITION FILE dmiiu-20260324_def.xml EX-101.DEF 27296
6 XBRL LABEL FILE dmiiu-20260324_lab.xml EX-101.LAB 37883
7 XBRL PRESENTATION FILE dmiiu-20260324_pre.xml EX-101.PRE 25916
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0285112-8k_drugs2_htm.xml XML 7005
Mailing Address 1 EAST BROWARD BOULEVARD SUITE 700 FORT LAUDERDALE FL 33301
Business Address 1 EAST BROWARD BOULEVARD SUITE 700 FORT LAUDERDALE FL 33301 954-870-3104
Drugs Made In America Acquisition II Corp. (Filer) CIK: 0002040475 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42863 | Film No.: 26838602
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)